Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation.

Mulla H, Nabi F, Nichani S, Lawson G, Firmin RK, Upton DR.

Br J Clin Pharmacol. 2003 Jan;55(1):23-31.

2.
3.

Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation.

Mulla H, McCormack P, Lawson G, Firmin RK, Upton DR.

Anesthesiology. 2003 Aug;99(2):275-82.

PMID:
12883399
4.

Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models.

Driscoll MS, Ludden TM, Casto DT, Littlefield LC.

J Pharmacokinet Biopharm. 1989 Apr;17(2):141-68.

PMID:
2795453
5.

Population pharmacokinetics of theophylline in premature Korean infants.

Kim SE, Kim BH, Lee S, Sohn JA, Kim HS, Cho JY, Yoon SH, Jang IJ, Yu KS, Lim KS.

Ther Drug Monit. 2013 Jun;35(3):338-44. doi: 10.1097/FTD.0b013e3182866695.

PMID:
23666573
6.

Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates.

Peters JW, Anderson BJ, Simons SH, Uges DR, Tibboel D.

Intensive Care Med. 2005 Feb;31(2):257-63. Epub 2005 Jan 28.

PMID:
15678314
7.

The population pharmacokinetics of theophylline in neonates and young infants.

Moore ES, Faix RG, Banagale RC, Grasela TH.

J Pharmacokinet Biopharm. 1989 Feb;17(1):47-66.

8.

Population pharmacokinetics of rectal theophylline in neonates.

Karlsson MO, Thomson AH, McGovern EM, Chow P, Evans TJ, Kelman AW.

Ther Drug Monit. 1991 May;13(3):195-200.

PMID:
1926271
9.

Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation.

Amaker RD, DiPiro JT, Bhatia J.

Antimicrob Agents Chemother. 1996 May;40(5):1139-42.

10.

Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea.

Fukuda T, Yukawa E, Kondo G, Maeda T, Shin-o T, Kondo Y, Imamura T, Irikura M, Irie T.

J Clin Pharm Ther. 2005 Dec;30(6):591-6.

PMID:
16336292
11.

Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.

Swart EL, Zuideveld KP, de Jongh J, Danhof M, Thijs LG, Strack van Schijndel RM.

Br J Clin Pharmacol. 2004 Feb;57(2):135-45.

12.

Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.

Kontny NE, Würthwein G, Joachim B, Boddy AV, Krischke M, Fuhr U, Thompson PA, Jörger M, Schellens JH, Hempel G.

Cancer Chemother Pharmacol. 2013 Mar;71(3):749-63. doi: 10.1007/s00280-013-2069-1. Epub 2013 Jan 13.

PMID:
23314734
13.

Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.

Zhou H, Mayer PR, Wajdula J, Fatenejad S.

J Clin Pharmacol. 2004 Nov;44(11):1235-43.

PMID:
15496641
14.

Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates.

Ahsman MJ, Hanekamp M, Wildschut ED, Tibboel D, Mathot RA.

Clin Pharmacokinet. 2010 Jun;49(6):407-19. doi: 10.2165/11319970-000000000-00000.

PMID:
20481651
15.
16.

Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block.

Rapp HJ, Molnár V, Austin S, Krohn S, Gädeke V, Motsch J, Boos K, Williams DG, Gustafsson U, Huledal G, Larsson LE.

Paediatr Anaesth. 2004 Sep;14(9):724-32.

PMID:
15330953
17.

Population pharmacokinetics of netilmicin in short-term prophylactic treatment.

Jauregizar N, Wald JA, Astobieta A, Rodriguez Sasiain JM, Lukas JC, Calvo R.

Br J Clin Pharmacol. 2003 Jun;55(6):552-9.

18.

[Population pharmacokinetic analysis of two theophylline formulations in premature neonates and infants with apnea].

Suda Y, Hanada K, Tsuchiwata S, Saito M, Nakamura T, Ito Y, Ishikawa Y, Kushida K, Ogata H.

Yakugaku Zasshi. 2008 Apr;128(4):635-40. Japanese.

19.

The pharmacokinetics of theophylline in premature neonates during the first few days after birth.

du Preez MJ, Botha JH, McFadyen ML, Holford NH.

Ther Drug Monit. 1999 Dec;21(6):598-603.

PMID:
10604818
20.

The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.

Shekar K, Fraser JF, Taccone FS, Welch S, Wallis SC, Mullany DV, Lipman J, Roberts JA; ASAP ECMO Study Investigators..

Crit Care. 2014 Dec 12;18(6):565. doi: 10.1186/s13054-014-0565-2.

Supplemental Content

Support Center